Literature DB >> 6589616

Synthesis of the templates for influenza virion RNA replication in vitro.

A R Beaton, R M Krug.   

Abstract

To elucidate the mechanism(s) of influenza viral RNA replication, we have developed an in vitro system in which the templates for viral RNA replication as well as the viral messenger RNAs (mRNAs) are synthesized. Because the synthesis of both the viral mRNAs and the template RNAs occurs in the nucleus of infected cells, we determined whether infected cell nuclei are active in the synthesis of these two types of transcripts in vitro. Nuclei isolated as early as 1-2 hr after infection catalyze the in vitro synthesis of both the viral mRNAs and template RNAs. The time course of appearance of these activities indicates that they most likely represent the transcriptional complexes functioning in vivo. Template RNA synthesis catalyzed by the nuclei in vitro is independent of concomitant protein synthesis; rather, it utilizes preformed proteins present in the nuclear preparations. This protein pool can be depleted by treating the infected cells with a protein synthesis inhibitor prior to the isolation of the nuclei, thereby rendering the nuclei inactive in template RNA synthesis in vitro. This activity can be restored by the addition of infected cell cytoplasmic extracts or of the high-speed supernatant fraction from these extracts. These results indicate that the cytoplasmic fraction from infected cells enables the viral transcription complex to continue transcription past the site at which termination occurs during viral mRNA synthesis and also suggest that this fraction enables the transcription complex to initiate transcription without the capped primer used in viral mRNA synthesis.

Mesh:

Substances:

Year:  1984        PMID: 6589616      PMCID: PMC391554          DOI: 10.1073/pnas.81.15.4682

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Globin mRNAs are primers for the transcription of influenza viral RNA in vitro.

Authors:  M Bouloy; S J Plotch; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro.

Authors:  S J Plotch; M Bouloy; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation.

Authors:  M R Miller; J J Castellot; A B Pardee
Journal:  Biochemistry       Date:  1978-03-21       Impact factor: 3.162

4.  Transcription and replication of influenza virus RNA.

Authors:  T Barrett; A J Wolstenholme; B W Mahy
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

5.  Segments of influenza virus complementary RNA synthesized in vitro.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

6.  Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts.

Authors:  J J Skehel; A J Hay
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

7.  Nuclear accumulation of influenza viral RNA transcripts and the effects of cycloheximide, actinomycin D, and alpha-amanitin.

Authors:  G E Mark; J M Taylor; B Broni; R M Krug
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

8.  Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs.

Authors:  A J Hay; G Abraham; J J Skehel; J C Smith; P Fellner
Journal:  Nucleic Acids Res       Date:  1977-12       Impact factor: 16.971

Review 9.  Vesicular stomatitis virus: mode of transcription.

Authors:  A D Banerjee; G Abraham; R J Colonno
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

10.  N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus.

Authors:  J T Patton; N L Davis; G W Wertz
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

View more
  20 in total

1.  Determination of influenza virus proteins required for genome replication.

Authors:  T S Huang; P Palese; M Krystal
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis.

Authors:  F Momose; C F Basler; R E O'Neill; A Iwamatsu; P Palese; K Nagata
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  The PB1 subunit alone can catalyze cRNA synthesis, and the PA subunit in addition to the PB1 subunit is required for viral RNA synthesis in replication of the influenza virus genome.

Authors:  Y Nakagawa; K Oda; S Nakada
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end.

Authors:  A R Beaton; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Pre-mRNA Processing Factor Prp18 Is a Stimulatory Factor of Influenza Virus RNA Synthesis and Possesses Nucleoprotein Chaperone Activity.

Authors:  M Minakuchi; K Sugiyama; Y Kato; T Naito; M Okuwaki; A Kawaguchi; K Nagata
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

6.  Antigenic reactivity and electrophoretic migrational heterogeneity of the three polymerase proteins of type A human and animal influenza viruses.

Authors:  R K Akkina
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Influenza virus PB1 protein is the minimal and essential subunit of RNA polymerase.

Authors:  M Kobayashi; T Toyoda; A Ishihama
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1.

Authors:  S K Biswas; D P Nayak
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity.

Authors:  M Hagen; T D Chung; J A Butcher; M Krystal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product.

Authors:  R M Krug; M Shaw; B Broni; G Shapiro; O Haller
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.